Legend Capital
China's New Horizon Health raises $66m Series C
China-based New Horizon Health, which produces home cancer test kits, has raised $66 million in a Series C round of funding led by VMS Group, a Hong Kong-based investment firm.
China's Luckin Coffee gains 20% after upsized IPO
China’s second largest coffee chain Luckin Coffee, which counts Centurium Capital and Joy Capital among its private equity investors, surged around 20% on its US debut following a $561 million IPO.
Primavera backs Chinese maths-focused education platform
Primavera Capital Group has led a RMB300 million ($45 million) Series D round for online mathematics education platform Yangcong 345, with participation from Beijing Kunlun Technology and existing backer Legend Capital.
PE-backed Luckin Coffee files for US IPO
Luckin Coffee, China’s second largest coffee shop chain, which counts Centurium Capital and Joy Capital among its private equity investors, has filed to list in the US.
Legend leads round for Chinese self-driving tech specialist
China and US-based autonomous driving technology developer Black Sesame has completed its Series B round of funding, raising around $100 million led by Junhai Chuangxin, an investment vehicle under Legend Capital.
VC-backed Ruhan drops on debut after $125m US IPO
Ruhan, a VC-backed Chinese celebrity incubator that creates online personalities who drive e-commerce activity, slipped 37% below its IPO price on the first day of trading following a $125 million NASDAQ offering.
VC-backed internet celebrity incubator files for US listing
Ruhan, an internet celebrity incubator backed by Legend Capital that is said to be the largest business of its kind by revenue in China, has filed to list on NASDAQ.
Deal focus: Legend backs Mancando’s offline network
Legend Capital sees Mancando's extensive network of brick-and-mortar outlets as the key to bringing greater supply chain efficiency to the Chinese auto parts industry
Legend leads $29m round for Chinese biotech player
Sciwind Biosciences, a Chinese drug developer focused on treating metabolic disorders, has raised RMB200 million ($29 million) in Series A funding led by Legend Capital, with participation from existing investors Shiyu Capital and Beijing-based biotech...
Chinese auto parts supplier raises $25m in Series A
Mancando, an automotive parts supplier based in Guangdong province, has raised RMB170 million ($25 million) in Series A funding led by Eastern Bell Venture Capital, with participation from Legend Capital.
Tencent invests $318m in recently-listed streaming site Bilibili
Tencent Holdings has agreed to invest $317.6 million in Bilibili, a VC-backed Chinese animation streaming platform that listed on NASDAQ in March.
Legend, Tiger back Chinese industrial e-commerce platform
Legend Capital and Tiger Global Management have led a $129 million Series C round for Zhenkunhang, a Chinese e-commerce platform that specializes in industrial products.
GIC leads $85m Series B for China's Harbour BioMed
Harbour BioMed, a China-based biopharmaceutical company focused on treatments for cancer and autoimmune disorders, has raised an $85 million Series B round led by Singapore’s GIC Private.
Legend Capital invests in talent agency CAA's China unit
Legend Capital has taken an equity interest in the China unit of Hollywood talent agency Creative Artists Agency (CAA), having facilitated a merger with Momentum Sports, a sports marketing and consulting business in which it is an investor.
China's Kemei Biotechnology raises $294m round
Legend Capital and Huaxing Healthcare Fund – a private equity arm of financial advisor China Renaissance – have led a RMB2 billion ($294 million) investment in Beijing Kemei Biotechnology, a Chinese in vitro diagnostics business.
Chinese coffee shop chain raises $200m, achieves unicorn status
Luckin Coffee, a Chinese coffee shop chain established last year, has raised $200 million in Series A funding from GIC Private, Centurium Capital, Legend Capital, and Joy Capital. Centurium, a GP established by ex-Warburg Pincus China head David Li, is...
Cancer drug developer Innovent Biologics files for HK IPO
Innovent Biologics, a Chinese drug developer company with a number of PE backers, has filed for an IPO in Hong Kong under recently introduced rules allowing listings by biotech companies with no revenue or profits.
Deal focus: Byton plans China luxury breakthrough
Legend Capital-backed Byton plans to pursue global expansion in the luxury electric car market with the help of a $500 million Series B round
Chinese smart vehicle start-up raises $500m
Byton, a China-based manufacturer of smart electric cars backed by Legend Capital, has secured a $500 million Series B funding round from a group of domestic strategic investors.
China used car trading business Uxin files for US IPO
Uxin Group, a Chinese e-commerce platform that specializes in used-car trading and related services, has filed for a US IPO. Jeneration Capital, Warburg Pincus, and Tiger Global Management are among the company’s PE backers.
Legend hits $156m first close on renminbi healthcare fund
Legend Capital has reached a first close of RMB1 billion ($156 million) on its second dedicated healthcare fund. A US dollar-denominated vehicle – also the VC firm’s second for the sector – is scheduled for launch in the third quarter.
Tencent leads $50m round for India's NewsDog
China's Tencent Holdings has led a $50 million Series C round for NewsDog, an Indian vernacular language news app founded by Chinese entrepreneurs.
Chinese long-term property rental players get PE funding
Two more Chinese online long-term property rental platforms – Uoko.com and Baletu.com – have received private equity funding as young people opt to rent rather than buy in a climate of high property prices.
Capital Group leads Series E for China’s Innovent Biologics
Capital Group Private Markets (CGPM), a private equity affiliate of US-based Capital Group Companies, has led a $150 million Series E round for Chinese biopharmaceutical developer Innovent Biologics.